Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
about
Human papillomavirus-16 modifies the association between fruit consumption and head and neck squamous cell carcinomaThe combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinomaHPV infection and cervical disease: a review.Seroprevalence of 34 human papillomavirus types in the German general population.Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infectionPrevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural UgandaSerological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile.Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfectionHigh-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental modelsPrevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with menHigh-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancerA competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youthThe relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population.Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service.Persistence of Trichomonas vaginalis serostatus in men over time.Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirionsAge-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global reviewClinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.Immunologic treatments for precancerous lesions and uterine cervical cancer.Review: current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme.Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.High-risk human papillomavirus seroprevalence in men and women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study.Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women.Natural History of HPV Infection across the Lifespan: Role of Viral Latency.Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.Prevalence of oral HPV infection in the United States, 2009-2010.Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women.Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
P2860
Q23917546-B272199F-0B91-42B7-8F9F-C8595C68CA17Q28387851-D2D4E704-24EA-4333-ACB6-946BEABB0989Q33159907-D35234F8-7507-445D-B51C-E9A2853D2D52Q33345224-35F655DE-9175-4683-A75B-48495E6AEF0AQ33704870-E814ACA6-8E95-4A2E-BB30-3D467975859EQ33760807-385FC9BA-A177-44ED-A743-C273F69F7D9CQ33880956-25AB3AF9-08D7-43DB-8E95-7DD82A15B7B1Q33947813-05085041-23CC-46AB-B007-86E5CB7B121BQ34037232-53C830AD-DB35-44DD-9C0C-D0A29501AD23Q34038946-66DE6E8D-81D9-4A7C-A8B5-3716BC2565E5Q34267472-C8D0941F-8E13-4F50-9D91-6DB3B46712BCQ34335370-920B96F1-0E5A-49AA-A562-899EF7837B8CQ34546550-A90D38CB-0441-4BA4-9355-1BDF2070EC27Q34583160-8CF595A9-6DE3-4725-9496-BA000F13A2EAQ34873067-59A29731-8FD5-4188-AB0C-362DFAB2D796Q35016793-E6673C35-482B-429D-805C-5CA8D858FC43Q35034741-A09BC195-CF02-48E7-B347-4E59FFFC03C1Q35088658-D0CF7595-768E-4E22-AEFC-A2BB51AD34E1Q35411802-97FBE4F0-A385-47EF-8194-BEAA742C2A55Q35677525-6BF22AAA-87A0-4241-ABA2-007C16C9CE81Q35902322-7C9125DF-726C-4744-AB34-3E1E826276A0Q36054475-8448C5F8-AE5D-406D-BDBD-C2E8EA2A838EQ36422554-425B62B2-29FA-4124-B36E-9BA9D5767B8BQ36609068-1DD3E44B-E8FE-4456-81F3-52541811E9BEQ36775528-FA34EC47-96DF-45BE-A63F-2EBAAD973E50Q36921606-D168D2FE-0F18-4FB7-84C4-82024EABD861Q37227140-C2571CA8-1CA9-4843-9045-15429154B853Q37703113-BEB38FA6-A176-49D4-804B-721558F63D92Q38110696-40985C59-F07F-4973-BF84-33C3D3B3C63FQ39122093-7CAEE359-47FE-40CD-A46B-A36B9AF3D38EQ40117849-A493D821-EF54-4F7E-B09C-A7079E29E791Q40355308-CBFB895B-6B41-4845-8FAE-B18EB1971E3BQ40603173-E2F00257-80B4-4C8F-8392-1210313E8A6AQ41932990-A4CB47EF-3045-4F4D-B5A1-E884080439B6Q42224757-57B5B395-131B-4CA1-9EAA-932862E77E82Q42280365-9005D890-E529-4022-94EA-CA778B935904Q43794722-CD2D5D7F-3B46-4EB4-A80A-4838652A5598Q50550711-E6824508-3803-409D-80FB-094B85A7DA53Q53430838-B3F7E08E-BE93-45F1-8BDD-42D123BBF575
P2860
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Determinants of human papillom ...... of 10 000 women in Costa Rica
@ast
Determinants of human papillom ...... of 10 000 women in Costa Rica
@en
type
label
Determinants of human papillom ...... of 10 000 women in Costa Rica
@ast
Determinants of human papillom ...... of 10 000 women in Costa Rica
@en
prefLabel
Determinants of human papillom ...... of 10 000 women in Costa Rica
@ast
Determinants of human papillom ...... of 10 000 women in Costa Rica
@en
P2093
P2860
P356
P1476
Determinants of human papillom ...... of 10 000 women in Costa Rica
@en
P2093
A C Rodriguez
A Hildesheim
M C Bratti
M E Sherman
M Schiffman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602088
P407
P577
2004-10-01T00:00:00Z